Eurand N.V. (NASDAQ: EURX) today announced the commercial availability of ZENPEP (pancrelipase) Delayed-Release Capsules, a pancreatic enzyme product (PEP) indicated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE